Telmisartan Prescribing at MAPLE ACCESS PARTNERSHIP LLP
Hypertension and heart failure | Cardiovascular System
Items (12m)
26
Total Quantity
686
NHS Cost
£147
vs National Avg
-55.2%
MAPLE ACCESS PARTNERSHIP LLP prescribed 26 items of Telmisartan over the last 12 months at a cost of £147 to the NHS. This is 55.2% below the national average prescribing rate. Telmisartan is classified under Hypertension and heart failure in the BNF.
Monthly Prescribing Trend
No monthly data available.
Prescribing Details
| Total Items | 26 |
|---|---|
| Total Quantity | 686 |
| Total NHS Cost | £147 |
| Presentations | 3 different forms |
| vs National Average | -55.2% |
Telmisartan Prescribing Comparison
| This practice | 26 items |
|---|---|
| National average per practice | 58 items |
| Difference | -55.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.